Security
Genelux Corporation Common Stock · GNLX
GNLXNASDAQCommon stockCurrentCIK 1231457Updated Oct 6, 2026
GNLX price & chart
Loading TradingView…
NASDAQ:GNLX on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
144 filing
Submission of Matters to a Vote of Security Holders
Items 5.07
144 filing
10-Q filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 24,987,000Source | 40,270,000Source | 26,205,000Source | 32,247,000Source | 45,179,000Source | 32,372,000Source | 38,985,000Source | 24,676,000Source | 19,027,000Source | 34,716,000Source | 27,893,000Source | 5,531,000Source |
| Property, Plant and Equipment, NetUSD | 1,794,000Source | 1,278,000Source | 4,603,000Source | 1,339,000Source | 1,306,000Source | 3,081,000Source | 1,287,000Source | 1,116,000Source | 2,170,000Source | 1,316,000Source | 1,170,000Source | 644,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 6,102,000Source | 9,184,000Source | 6,546,000Source | 7,858,000Source | 9,273,000Source | 16,206,000Source | 4,061,000Source | 5,333,000Source | 8,565,000Source | 9,418,000Source | 397,000Source |
| Assets, CurrentUSD | 21,552,000Source | 35,967,000Source | 19,144,000Source | 29,235,000Source | 34,870,000Source | 26,754,000Source | 35,945,000Source | 21,204,000Source | 15,130,000Source | 31,548,000Source | 24,203,000Source | 1,892,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 637,000Source | 1,910,000Source | 474,000Source | 1,263,000Source | 1,234,000Source | 545,000Source | 843,000Source | 1,577,000Source | 535,000Source | 653,000Source | 1,012,000Source | 1,495,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,518,000Source | 1,930,000Source | 2,312,000Source | 1,600,000Source | 2,098,000Source | 2,393,000Source | 1,680,000Source | 2,264,000Source | 1,583,000Source | 1,760,000Source | 2,428,000Source | 1,335,000Source |
| Other Assets, NoncurrentUSD | 123,000Source | 92,000Source | 146,000Source | 73,000Source | 92,000Source | 144,000Source | 73,000Source | 92,000Source | 144,000Source | 92,000Source | 92,000Source | 92,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 6,396,000Source | 7,179,000Source | 10,092,000Source | 8,349,000Source | 7,510,000Source | 9,451,000Source | 9,139,000Source | 9,592,000Source | 7,483,000Source | 8,442,000Source | 8,420,000Source | 41,314,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | — | — | — | — | — | — | — | — | — | — | 22,000Source |
| Common Stock, Value, IssuedUSD | 38,000Source | 35,000Source | 45,000Source | 38,000Source | 35,000Source | 45,000Source | 38,000Source | 27,000Source | 38,000Source | 35,000Source | 27,000Source | 9,000Source |
| Additional Paid in CapitalUSD | 293,269,000Source | 275,782,000Source | 318,440,000Source | 290,631,000Source | 274,028,000Source | 315,780,000Source | 289,097,000Source | 244,869,000Source | 295,468,000Source | 278,001,000Source | 241,389,000Source | 154,401,000Source |
| Retained Earnings (Accumulated Deficit)USD | -274,291,000Source | -242,417,000Source | -301,937,000Source | -266,341,000Source | -235,950,000Source | -292,466,000Source | -258,885,000Source | -229,374,000Source | -283,538,000Source | -251,393,000Source | -221,524,000Source | -189,784,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 8,000Source | 124,000Source | -2,000Source | 3,000Source | -11,000Source | -5,000Source | 29,000Source | -5,000Source | 9,000Source | 64,000Source | 14,000Source | 2,000Source |
| Stockholders' Equity Attributable to ParentUSD | 18,591,000Source | 33,091,000Source | 16,113,000Source | 23,898,000Source | 37,669,000Source | 22,921,000Source | 29,846,000Source | 15,084,000Source | 11,544,000Source | 26,274,000Source | 19,473,000Source | -35,783,000Source |
| Liabilities and EquityUSD | 24,987,000Source | 40,270,000Source | 26,205,000Source | 32,247,000Source | 45,179,000Source | 32,372,000Source | 38,985,000Source | 24,676,000Source | 19,027,000Source | 34,716,000Source | 27,893,000Source | 5,531,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 5,126,000Source | 5,555,000Source | 7,998,000Source | 6,988,000Source | 5,803,000Source | 7,272,000Source | 7,689,000Source | 7,805,000Source | 6,225,000Source | 6,903,000Source | 6,554,000Source | 31,626,000Source |
| Operating Lease, Liability, CurrentUSD | 354,000Source | 415,000Source | 326,000Source | 345,000Source | 500,000Source | 316,000Source | 337,000Source | 584,000Source | 427,000Source | 329,000Source | 653,000Source | 266,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,270,000Source | 1,624,000Source | 2,094,000Source | 1,361,000Source | 1,707,000Source | 2,179,000Source | 1,450,000Source | 1,787,000Source | 1,258,000Source | 1,539,000Source | 1,866,000Source | 1,164,000Source |
| Additional Financial Items | ||||||||||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | 35,060,000Source | — | 28,100,000Source | 40,449,000Source | — | 35,102,000Source | 19,627,000Source | — | 30,895,000Source | 23,191,000Source | — |
| Deferred Revenue, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 170,000Source |
| Short-term InvestmentsUSD | 16,223,000Source | 27,955,000Source | 9,500,000Source | 21,426,000Source | 25,778,000Source | 16,900,000Source | 18,896,000Source | 15,566,000Source | — | 22,330,000Source | 13,773,000Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,394,000Source | 1,423,000Source | 5,871,000Source | 5,738,000Source | 2,515,000Source | 2,415,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -6,059,000Source | -5,435,000Source | -25,268,000Source | -21,228,000Source | -20,275,000Source | -3,571,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -8,539,000Source | 3,509,000Source | 12,141,000Source | -8,131,000Source | -14,724,000Source | -49,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 921,000Source | 30,000Source | 1,098,000Source | 381,000Source | 1,025,000Source | 49,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 18,538,000Source | 9,567,000Source | 9,895,000Source | 28,506,000Source | 44,020,000Source | -478,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 3,940,000Source | 7,641,000Source | -3,232,000Source | -853,000Source | 9,021,000Source | -4,098,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 4,692,000Source | 6,102,000Source | 9,184,000Source | 6,546,000Source | 9,273,000Source | 16,206,000Source | 5,333,000Source | 8,565,000Source | 9,418,000Source | 397,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | 72,000Source | 264,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 2,635,000Source | 1,755,000Source | 2,273,000Source | 1,482,000Source | 1,781,000Source | 1,532,000Source | 7,576,000Source | 5,738,000Source | 2,515,000Source | 2,415,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | — | 35,060,000Source | — | 28,100,000Source | — | 35,102,000Source | — | 30,895,000Source | 23,191,000Source | — |
| DepreciationUSD | — | — | 61,000Source | 56,000Source | 10,000Source | 62,000Source | 9,000Source | 59,000Source | 244,000Source | 235,000Source | 499,000Source | 553,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | -402,000Source | — |
| General and Administrative ExpenseUSD | — | — | 3,453,000Source | 2,890,000Source | 3,137,000Source | 3,034,000Source | 3,393,000Source | 3,118,000Source | 13,371,000Source | 12,706,000Source | 11,568,000Source | 5,003,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | — | 1,100,000Source |
| Investment Income, InterestUSD | — | — | 175,000Source | 222,000Source | 127,000Source | 224,000Source | 173,000Source | 184,000Source | 711,000Source | 700,000Source | 244,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,950,000Source | -6,467,000Source | -9,471,000Source | -7,456,000Source | -8,928,000Source | -7,492,000Source | -32,145,000Source | -29,869,000Source | -28,297,000Source | -5,207,000Source |
| Nonoperating Income (Expense)USD | — | — | 244,000Source | 474,000Source | 174,000Source | 336,000Source | 243,000Source | 324,000Source | 1,069,000Source | 1,827,000Source | -4,132,000Source | -1,094,000Source |
| Operating ExpensesUSD | — | — | 8,194,000Source | 6,941,000Source | 9,645,000Source | 7,792,000Source | 9,171,000Source | 7,816,000Source | 33,222,000Source | 31,704,000Source | 24,335,000Source | 14,081,000Source |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | 14,398,000Source | 2,461,000Source | 18,261,000Source | 29,000,000Source | 13,699,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 18,525,000Source | 9,553,000Source | 9,553,000Source | — | 25,142,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 13,000Source | 14,000Source | 14,000Source | — | 1,474,000Source | — |
| Stock or Unit Option Plan ExpenseUSD | — | — | — | — | — | — | 10,900,000Source | — | 11,700,000Source | — | — | — |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | 5,000Source | 135,000Source | 3,000Source | -26,000Source | -14,000Source | -35,000Source | -55,000Source | 50,000Source | 12,000Source | — |
| Realized Investment Gains (Losses) | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | — | — | 8,000Source | 8,000Source | 170,000Source | 11,068,000Source |
| Operating Income (Loss)USD | — | — | -8,194,000Source | -6,941,000Source | -9,645,000Source | -7,792,000Source | -9,171,000Source | -7,816,000Source | -33,214,000Source | -31,696,000Source | -24,165,000Source | -3,013,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | — | 1,100,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,950,000Source | -6,467,000Source | -9,471,000Source | -7,456,000Source | -8,928,000Source | -7,492,000Source | -32,145,000Source | -29,869,000Source | -28,297,000Source | -5,207,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.21Source | -0.19Source | -0.21Source | -0.2Source | -0.2Source | -0.21Source | -0.86Source | -0.95Source | -1.16Source | -0.57Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.21Source | -0.19Source | -0.21Source | -0.2Source | -0.2Source | -0.21Source | -0.86Source | -0.95Source | -1.16Source | -0.57Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 37,893,314Source | 34,532,355Source | 44,959,426Source | 37,946,330Source | 44,150,958Source | 34,926,075Source | 37,176,527Source | 31,450,727Source | 24,429,278Source | 9,116,489Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 37,893,314Source | 34,532,355Source | 44,959,426Source | 37,946,330Source | 44,150,958Source | 34,926,075Source | 37,176,527Source | 31,450,727Source | 24,429,278Source | 9,116,489Source |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 3,453,000Source | 2,890,000Source | 3,137,000Source | 3,034,000Source | 3,393,000Source | 3,118,000Source | 13,371,000Source | 12,706,000Source | 11,568,000Source | 5,003,000Source |
| Investment Income, InterestUSD | — | — | 175,000Source | 222,000Source | 127,000Source | 224,000Source | 173,000Source | 184,000Source | 711,000Source | 700,000Source | 244,000Source | — |
| Nonoperating Income (Expense)USD | — | — | 244,000Source | 474,000Source | 174,000Source | 336,000Source | 243,000Source | 324,000Source | 1,069,000Source | 1,827,000Source | -4,132,000Source | -1,094,000Source |
| Operating ExpensesUSD | — | — | 8,194,000Source | 6,941,000Source | 9,645,000Source | 7,792,000Source | 9,171,000Source | 7,816,000Source | 33,222,000Source | 31,704,000Source | 24,335,000Source | 14,081,000Source |
| Research and Development ExpenseUSD | — | — | 4,741,000Source | 4,051,000Source | 6,508,000Source | 4,758,000Source | 5,778,000Source | 4,698,000Source | 19,851,000Source | 18,998,000Source | 12,767,000Source | 9,078,000Source |
| Realized Investment Gains (Losses) | — | — | — | — | — | — | — | — | — | — | — | — |
Filing attachments
ex107.htm · S-8 · 2026-03-19
Calculation of Filing Fee Tables S-8 GENELUX Corp ──────────────────────────────────── Table 1: Newly Registered Securities ──────────────────────────────────────── Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount o…
Read attachment ↗ex99-1.htm · 8-K · 2026-01-08
Exhibit 99.1 Genelux Corporation Announces Proposed Public Offering of Common Stock WESTLAKE VILLAGE, Calif., January 7, 2026 - Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced that it has commenced a proposed underwritten public offering of its common stock. In addition, Genelux expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the number of shares of common stock sold in connection with the pr…
Read attachment ↗ex99-2.htm · 8-K · 2026-01-08
Exhibit 99.2 Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock WESTLAKE VILLAGE, Calif., January 8, 2026 - Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share. All of the shares in the offering are to be sold by Genelux. The gross proceeds to Genelux from t…
Read attachment ↗ex99-1.htm · 8-K · 2026-01-05
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials - Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed immunochemotherapy across ongoing SCLC and NSCLC trials; enrollment ongoing - - In platinum-relapsed or platinum-refractory advanced SCLC, two of three partial responses (PRs) occurred in the h…
Read attachment ↗ex4-1.htm · 8-K · 2025-03-25
EX-4.1 3 ex4-1.htm Exhibit 4.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES FOR WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION …
Read attachment ↗